An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

Key Insights for Pharma Manufacturers Regarding the AKS - In a series of recent legal challenges initiated by the ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

The changes proposed by the industry are needed to ensure Europe remains a competitive location to research, develop and ...

Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for ...

WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them ...

Top interviews with industry experts driving change in pharmaceutical production. Standout news pieces covering recent breakthroughs, challenges, and market shifts. Key pieces written by our ...

President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price ...

Life sciences companies face an impending “tax policy trifecta” including potential TCJA expiration, U.S. trade and ...